John Powell Leachman
关联发行主体 15 家 申报季度 2024Q4 – 2026Q3 主要属地 Georgia
申报角色：董事 21 次
口径：本页聚合 SEC Form D 申报中「相关人员」栏出现的同一姓名字符串。Form D 不提供人员唯一编号，同名不代表同一自然人；申报相关人员（高管/董事/发起人）不等于基金经理或投资决策人。本页仅为公示申报事实检索，不含任何业绩或评价信息。
关联的基金发行主体（按最近申报排序）
近两个季度的申报附产品详情页链接；更早季度的申报仅列名称与事实，可前往 基金产品库 › 按季度检索。
| 发行主体 | 基金类型 | 最近申报 | 属地 |
|---|---|---|---|
| HB-WIN 2024 Lumata Series, a series of HB-WIN LLC | |||
| Harbright 2026 VQ Biomedical Series, a series of Harbright LLC | |||
| HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC | |||
| HB-WIN 2025 Invicta Water Series, a series of HB-WIN LLC | |||
| HB-WIN 2026 Skillmaker Series - a series of HB-WIN LLC | |||
| HB-WIN 2026 inSoma Series - a series of HB-WIN LLC | |||
| HB-WIN 2024 Deep Blue Series, a series of HB-WIN LLC | 风险投资基金 | 2025Q4 | CARY, North Carolina |
| HB-WIN 2023 SonoVascular Series, a series of HB-WIN LLC | 风险投资基金 | 2025Q4 | CARY, North Carolina |
| HB-WIN 2023 Voxel Series, a series of HB-WIN LLC | 风险投资基金 | 2025Q4 | CARY, North Carolina |
| Harbright 2025 Materna Series, a series of Harbright LLC | 风险投资基金 | 2025Q4 | CARY, North Carolina |
| Harbright 2024 SonoVascular Series, a series of Harbright LLC | 风险投资基金 | 2025Q4 | CARY, North Carolina |
| HB-WIN 2025 Eventuall Series, a series of HB-WIN LLC | 风险投资基金 | 2025Q3 | CARY, North Carolina |
| HB-WIN 2025 Ariso Series, a series of HB-WIN LLC | 风险投资基金 | 2025Q3 | CARY, North Carolina |
| HB-WIN 2025 Cosmonic Series, a series of HB-WIN LLC | 风险投资基金 | 2025Q2 | CARY, North Carolina |
| HB-WIN 2024 VQ Biomedical Series, a series of HB-WIN LLC | 风险投资基金 | 2024Q4 | CARY, North Carolina |
申报活动统计 近 8 季 · 公示口径
申报活动按季度（全部申报记录，含同一主体多次申报）
2024Q4
3 次 · 14%
2025Q1
1 次 · 5%
2025Q2
2 次 · 10%
2025Q3
2 次 · 10%
2025Q4
7 次 · 33%
2026Q2
3 次 · 14%
2026Q3
3 次 · 14%
关联主体的基金类型分布
风险投资基金
15 家 · 100%
仅描述该姓名字符串在申报公示中的出现结构，不构成对个人身份、职务或业绩的认定。
